Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors clinical trial (NCT07300150). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential side effects of PT0511 and cetuximab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors clinical trial (NCT07300150). Contact the study team or your healthcare provider for specific answers.

Question 3

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors clinical trial (NCT07300150). Contact the study team or your healthcare provider for specific answers.

Question 4

What will the treatment schedule look like if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors clinical trial (NCT07300150). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors clinical trial (NCT07300150). Contact the study team or your healthcare provider for specific answers.

What this study is about